- Home
- RELL vs ZURA Comparison
RELL vs ZURA Comparison
Compare RELL & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELL
- ZURA
- Stock Information
- Founded
- RELL 1947
- ZURA 2022
- Country
- RELL United States
- ZURA United States
- Employees
- RELL N/A
- ZURA N/A
- Industry
- RELL Electronic Components
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RELL Technology
- ZURA Health Care
- Exchange
- RELL Nasdaq
- ZURA Nasdaq
- Market Cap
- RELL 149.6M
- ZURA 137.2M
- IPO Year
- RELL N/A
- ZURA N/A
- Fundamental
- Price
- RELL $10.05
- ZURA $3.74
- Analyst Decision
- RELL
- ZURA Strong Buy
- Analyst Count
- RELL 0
- ZURA 9
- Target Price
- RELL N/A
- ZURA $11.38
- AVG Volume (30 Days)
- RELL 57.4K
- ZURA 430.2K
- Earning Date
- RELL 01-06-2026
- ZURA 11-13-2025
- Dividend Yield
- RELL 2.35%
- ZURA N/A
- EPS Growth
- RELL N/A
- ZURA N/A
- EPS
- RELL 0.01
- ZURA N/A
- Revenue
- RELL $209,791,000.00
- ZURA N/A
- Revenue This Year
- RELL $4.72
- ZURA N/A
- Revenue Next Year
- RELL $14.93
- ZURA N/A
- P/E Ratio
- RELL $835.11
- ZURA N/A
- Revenue Growth
- RELL 6.17
- ZURA N/A
- 52 Week Low
- RELL $7.57
- ZURA $0.97
- 52 Week High
- RELL $15.51
- ZURA $4.68
- Technical
- Relative Strength Index (RSI)
- RELL 48.63
- ZURA 50.73
- Support Level
- RELL $9.37
- ZURA $3.57
- Resistance Level
- RELL $10.28
- ZURA $4.10
- Average True Range (ATR)
- RELL 0.46
- ZURA 0.31
- MACD
- RELL -0.06
- ZURA -0.07
- Stochastic Oscillator
- RELL 58.84
- ZURA 29.78
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.